Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • AmelieR
    Junior Member
    • Feb 2017
    • 1

    #1

    Bio-statistics for metatranscriptomic

    Hi everybody,
    I am trying to identified differentially expressed (DE) genes of several bacterial metatranscriptomes.

    To sum up the experimental plan. We have 2 bacterial communities (named E and U) inoculated under 3 different conditions A, B and C (reference condition). I collected both DNA and RNA from time 7 and 9 and also the experiment was performed in duplicate.
    We sequenced RNA (each 24 samples) and metagenome (from pooled of DNA of several samples).

    I assembled and annotated metagenome (141 921 contigs) and use it as reference to map RNA reads with bowtie2.

    I performed DESeq2 analysis on those result and I obtained a large part of DE gene. So I used edgeR to change the normalization way (I had tested TMM, RLE and upperquartile methods) and I obtained around 10 000 DE genes for each comparison of condition (AvsC BvsC and AvsB).

    The problem is that I don't know what is the next step. With a small list of DE gene I would blast the sequence on NCBI and try to identified from which bacterial species, this gene came from and try to identified metabolism pathwas by hand. But with a too large number of DE gene, I don't know how to do.

    Do you think that I have to find another way of normalization to reduce the number of DE gene? Or do you have any idea of software I could use to group those gene by "category" or "class" to go throught the metabolic pathway?

    Thank's for your help.

    Amélie

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...